Recent studies have shown that PPARα-deficient mice are remarkably sensitive to DEN(diethylnitrosamine)-induced liver cancer, and PPARα inhibits HCC development by mediating the NF-κB pathway (29). Here, NFKB1 is linked to hepatocellular carcinoma.